NNovartis Read More Alteogen Signs $3.2 Billion Licensing Deal With Novartis2026-09-02 A view of Alteogen’s headquarters and research center. Photo courtesy of Alteogen Alteogen (196170.KQ) has signed a technology…
NNovartis Read More Alteogen Licenses ALT-B4 Platform to Novartis in Deal Worth Up to $3.2 Billion2026-09-02 An exterior view of Alteogen’s headquarters and research center. Photo courtesy of Alteogen Alteogen (196170) has signed a…
RRoche Read More Wilson Sonsini Advises Foresight on Roche Settlement and Licensing Agreement2026-04-29 On August 29, 2025, Foresight Diagnostics, a privately held cancer diagnostics company and CLIA-registered laboratory, announced that it…